To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that medications for Parkinson's disease are (a) available during the covid-19 outbreak and (b) at the end of the transition period.
9 July 2020
As part of our concerted national efforts in response to the COVID-19 pandemic, we will continue doing everything we can to ensure patients continue to have access to safe and effective medicines, including those used in the treatment of Parkinson’s disease.
The Department has well-established procedures to deal with medicine shortages and is working closely with industry, the National Health Service and others in the supply chain to reduce the likelihood of future shortages resulting from COVID-19 or any other cause.
The Government, pharmaceutical industry and NHS will always work closely together to help ensure patients have access to the medicines and treatments they need under all scenarios including those medicines used in the treatment of Parkinson’s disease.